clinical and genomic landscape of breast cancers carrying ccne1 amplification
Published 1 year ago • 66 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
2:03
the landscape of oral serds and their potential in er breast cancer
-
3:26
future of genomics in breast cancer care
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
6:38
physician adoption of ngs in the care of breast cancer patients
-
0:55
the clinical impact of gene expression assays on early luminal breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
1:45
impact of ngs on breast cancer diagnosis and treatment
-
1:12
ctdna in breast cancer: clinical decision making and future perspectives
-
1:13
landscape of breast cancer services in europe
-
5:16
differences in genomic landscape between african americans and caucasians with prostate cancer
-
1:26
the clinical applications of mrd in breast cancer
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
1:20
future role of genomic tools in breast cancer treatment
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
3:01
novel mechanisms of cdh1 inactivation in breast invasive lobular carcinoma using ai and genomics
-
2:08
examining the role of tissue-agnostic ctdna monitoring in breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
6:40
overcoming resistance to parpi in brca1-deficient breast cancer with sting agonists